Research workbench
Mouse rankl structure at 1.9A resolution
Analyse Mouse rankl structure at 1.9A resolution in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.
- PDB
- 1S55
- Type
- protein
- Length
- 468 residues
- Chains
- 3
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Tumor necrosis factor ligand superfamily member 11
- UniProt
- O35235
- Ligands
- CL
- Pockets
- 4 · best druggability 0.72
Structure
x-ray diffraction · 1 distinct chain · 4% helix, 57% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A, B, C | Tumor necrosis factor ligand superfamily member 11 | protein | 156 | 4% helix, 57% strand | O35235 |
Ligands and binding sites
- CL · Chloride ion · ion · 3 copies · chains A, C, B
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
4 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 52 | 0.72 | 0.99 | 12 | empty |
| 2 | 316 | 0.65 | 0.81 | 38 | empty |
| 3 | 62 | 0.38 | 0.79 | 14 | empty |
| 4 | 53 | 0.28 | 0.75 | 20 | CL |
Interfaces
3 interfaces between chains.
- A–C · 1104 Ų buried · 20 hydrogen bonds · protein-protein
- A–B · 1080 Ų buried · 20 hydrogen bonds · protein-protein
- B–C · 1051 Ų buried · 18 hydrogen bonds · protein-protein
Compared structures
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt O35235
- Elsewhere: RCSB PDB 1S55 · PDBe 1S55 · UniProt O35235
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.